Validation of the Korean version of the composite autonomic symptom scale-31 (COMPASS-31)

2018 ◽  
Vol 46 ◽  
pp. e93-e94
Author(s):  
Y. Kim ◽  
J.M. Seok ◽  
J. Youn ◽  
J.-H. Min ◽  
J.W. Cho ◽  
...  
Keyword(s):  
Symptom Scale ◽  
Autonomic Symptom ◽  
Korean Version

scholarly journals Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson’s disease

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0258897
Author(s):  
Jong Hyeon Ahn ◽  
Jin Myoung Seok ◽  
Jongkyu Park ◽  
Heejeong Jeong ◽  
Younsoo Kim ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Autonomic Dysfunction ◽  
Symptom Scale ◽  
Autonomic Symptom ◽  
Retest Reliability ◽  
Autonomic Symptoms ◽  
Korean Version ◽  
Neurologic Disorders ◽  
Test Retest Reliability

Purpose The composite autonomic symptom scale-31 (COMPASS-31) is a self-rated questionnaire that evaluates diverse autonomic symptoms. In the present study, we developed the Korean version of the COMPASS-31 (K-COMPASS-31) with appropriate translation, and verified its reliability and internal and external validity in patients with Parkinson’s disease (PD). Methods The original COMPASS-31 was translated independently into Korean by two bilingual neurologists. Test-retest reliability was evaluated at a 2-week interval. We investigated the correlations between the K-COMPASS-31, the scale for outcomes in PD-autonomic (SCOPA-AUT), and the results of an autonomic function test (AFT), respectively. Results A total of 90 patients with PD (47 females; mean age, 63.4 ± 10.8 years) were enrolled. The K-COMPASS-31 showed excellent test-retest reliability (intra-class correlation coefficient = 0.874, p < 0.001) and internal validity (Cronbach’s α-coefficient = 0.878). The COMPASS-31 was positively correlated with SCOPA-AUT (r = 0.609, p < 0.001) and the results of the AFT. Conclusions In conclusion, the K-COMPASS-31 showed excellent reliability and validity for the assessment of autonomic symptoms in PD patients. The K-COMPASS-31 is an easy-to-repeat and widely used tool for investigating autonomic dysfunction in various neurologic disorders and enables comparison of autonomic dysfunction among neurologic disorders. We recommend the K-COMPASS-31 as a valid instrument for use in clinical practice for patients with PD.

scholarly journals Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study

2021 ◽  
Author(s):  
Alex Buoite Stella ◽  
Giovanni Furlanis ◽  
Nicolò Arjuna Frezza ◽  
Romina Valentinotti ◽  
Milos Ajcevic ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Heart Rate ◽  
Orthostatic Intolerance ◽  
Neurological Symptoms ◽  
Postural Tachycardia Syndrome ◽  
Symptom Scale ◽  
Autonomic Symptom ◽  
Postural Tachycardia ◽  
Ambulatory Services

AbstractThe autonomic nervous system (ANS) can be affected by COVID-19, and dysautonomia may be a possible complication in post-COVID individuals. Orthostatic hypotension (OH) and postural tachycardia syndrome (POTS) have been suggested to be common after SARS-CoV-2 infection, but other components of ANS function may be also impaired. The Composite Autonomic Symptom Scale 31 (COMPASS-31) questionnaire is a simple and validated tool to assess dysautonomic symptoms. The aim of the present study was to administer the COMPASS-31 questionnaire to a sample of post-COVID patients with and without neurological complaints. Participants were recruited among the post-COVID ambulatory services for follow-up evaluation between 4 weeks and 9 months from COVID-19 symptoms onset. Participants were asked to complete the COMPASS-31 questionnaire referring to the period after COVID-19 disease. Heart rate and blood pressure were manually taken during an active stand test for OH and POTS diagnosis. One-hundred and eighty participants were included in the analysis (70.6% females, 51 ± 13 years), and OH was found in 13.8% of the subjects. Median COMPASS-31 score was 17.6 (6.9–31.4), with the most affected domains being orthostatic intolerance, sudomotor, gastrointestinal and pupillomotor dysfunction. A higher COMPASS-31 score was found in those with neurological symptoms (p < 0.01), due to more severe orthostatic intolerance symptoms (p < 0.01), although gastrointestinal (p < 0.01), urinary (p < 0.01), and pupillomotor (p < 0.01) domains were more represented in the non-neurological symptoms group. This study confirms the importance of monitoring ANS symptoms as a possible complication of COVID-19 disease that may persist in the post-acute period.

scholarly journals Validation of the Korean version of the Boston Autonomic Symptom Questionnaire

2021 ◽  
Vol 17 (3) ◽  
pp. 463
Author(s):  
Eun Hee Sohn ◽  
Christopher H. Gibbons ◽  
Roy Freeman ◽  
Ae Young Lee ◽  
Mi Sook Jung ◽  
...  
Keyword(s):  
Autonomic Symptom ◽  
Korean Version ◽  
Symptom Questionnaire

scholarly journals Validity and Reliability of the Korean Version of the Hyperthyroidism Symptom Scale

2018 ◽  
Vol 33 (1) ◽  
pp. 70 ◽  
Author(s):  
Jie-Eun Lee ◽  
Dong Hwa Lee ◽  
Tae Jung Oh ◽  
Kyoung Min Kim ◽  
Sung Hee Choi ◽  
...  
Keyword(s):  
Validity And Reliability ◽  
Symptom Scale ◽  
Korean Version

scholarly journals Clinical Assessment Scales in Autonomic Nervous System Disorders

2021 ◽  
Vol 39 (2 Suppl) ◽  
pp. 60-76
Author(s):  
Eun Bin Cho ◽  
Ki-Jong Park
Keyword(s):  
Nervous System ◽  
Autonomic Nervous System ◽  
Scoring Systems ◽  
Signs And Symptoms ◽  
Self Report ◽  
Symptom Scale ◽  
Autonomic Symptom ◽  
Autonomic Nervous ◽  
Autonomic Nervous System Disorders ◽  
Assessment Scales

The autonomic nervous system plays an important role in maintaining homeostasis mediated by the parasympathetic, sympathetic and enteric systems. Autonomic failure adversely affects body function and may increase morbidity and mortality. Therefore, the scoring systems, such as Ewing’s classification and Composite Autonomic Scoring Scale (CASS), were developed to detect and quantify autonomic deficits, primarily focusing on the cardiovascular reflex system. Autonomic disorders manifest with a myriad of symptoms resulting from the dysfunction of the gastrointestinal, genitourinary, secretomotor, pupillomotor systems as well as cardiovascular system. Several self-report questionnaires, such as Composite Autonomic Symptom Scale (COMPASS), Scale for Outcomes in Parkinson’s disease for Autonomic Symptoms (SCOPA-AUT), Survey of Autonomic Symptom (SAS), were also used to support to detect various signs and symptoms of autonomic dysfunction in clinical settings. In this review, we introduce clinically useful assessment scales in autonomic nervous system disorders.

scholarly journals Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy

2015 ◽  
Vol 22 (7) ◽  
pp. 1124-1130 ◽  
Author(s):  
R. Treister ◽  
K. O'Neil ◽  
H. M. Downs ◽  
A. L. Oaklander
Keyword(s):  
Symptom Scale ◽  
Autonomic Symptom ◽  
Small Fiber

scholarly journals The translation of the Vertigo Symptom Scale into Afrikaans: A pilot study

2011 ◽  
Vol 58 (1) ◽  
Author(s):  
Christine Rogers ◽  
Jacques De Wet ◽  
Ayanda Gina ◽  
Ladine Louw ◽  
Musa Makhoba ◽  
...  
Keyword(s):  
Pilot Study ◽  
Roc Curve ◽  
Delphi Technique ◽  
Clinical Problem ◽  
Clinical Implications ◽  
Good Sensitivity ◽  
Symptom Scale ◽  
Autonomic Symptom ◽  
And Control ◽  
Common Clinical Problem

Vertigo is a common clinical problem that is challenging to diagnose and treat. While it has a broad range of aetiologies, the association between vestibular disturbance and anxiety is well established. The Vertigo Symptom Scale (VSS) is a questionnaire that assesses both dizziness and dizziness-related anxiety. The aim of this study was twofold. First, a translation of the VSS into Afrikaans was evaluated using the Delphi technique. Consensus was achieved within the Delphi rounds and a final tool was agreed upon. Second, the Afrikaans Vertigo Symptom Scales (AVSS) was piloted on a sample of vertiginous and control participants. The results of the pilot study yielded significant statistical differences between the groups on both subscales of the tool (vertigo symptom scale and anxiety and autonomic symptom scale). Results suggest that the AVSS is able to identify patients with vertiginous disturbance and anxiety. The AVSS presents with good sensitivity and specificity as measured by the ROC curve. Clinical implications are discussed.

The Korean Version of the Voice Symptom Scale for Patients with Thyroid Operation, and Its Use in a Validation and Reliability Study

2018 ◽  
Vol 32 (3) ◽  
pp. 367-373 ◽  
Author(s):  
Hee Young Son ◽  
Chang-Yoon Lee ◽  
Kyung A. Kim ◽  
Sina Kim ◽  
Hee Seok Jeong ◽  
...  
Keyword(s):  
Reliability Study ◽  
Symptom Scale ◽  
Korean Version ◽  
Thyroid Operation ◽  
The Voice
Sign in / Sign up

Export Citation Format

Share Document